MRFF 2020 Early Stage Translation and Commercialisation Support Grant Opportunity

Overview

The 2020 Early Stage Translation and Commercialisation Support Grant Opportunity was announced as part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. This initiative aims to support early-stage health and medical research and innovation in Australia through to proof-of-concept and beyond, providing opportunities for commercialisation. The objective of this grant opportunity is to provide grants of financial assistance to support early stage Australian medical research and medical innovation projects in the following four streams: Stream 1: preclinical medical research or medical innovation projects with commercial potential Stream 2: early clinical development of novel drugs, or novel uses for existing drugs, with commercial potential Stream 3: early clinical development of medical devices with commercial potential Stream 4: early stage development of digital health technologies with commercial potential. Each will be a separate funding stream. The top ranked project in each Stream will be funded. Applications to this grant opportunity must propose research that addresses one of the four Streams of research. Applicants must specify the Stream to which they are applying in their application. An organisation can submit a maximum of one application per Stream, however can be awarded funding from a maximum of two Streams. The grant opportunity will not fund organisations to progress their own early stage medical research and medical innovation projects.